Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
Results 21 to 30 of total 475
Active substances from approved pancreatic drugs prevent virus entry into the cell
HZI researchers Luka Cicin-Sain and Carlos Guzmán on future approaches to stop new pathogens more quickly
"Goal is to identify lead structure for new antibiotic in three years"
Saarbrücken researchers develop novel strategy for treating hospital germs
RNA sequencing reveals cause of relapse in immunotherapy of bone marrow cancer
Researchers at TU Braunschweig and HZI succeed in developing neutralizing anti-SARS-CoV-2 antibodies from immune cells of healthy donors
HZI bioinformaticians have developed a web resource that predicts the spread of SARS-CoV-2 variants
Extensive testing, faster contact tracing and rapid vaccination Basis for possible openings
HZI immunologist Jochen Hühn coordinates EU-funded doctoral programme
New tool aims to make HCV vaccine search easier
You can also find a selection of our press releases on the page of Informationsdienst Wissenschaft